 |
인쇄하기
취소
|
KFDA approves new anti-impotency drug
The Korea Food and Drug Administration (KFDA) yesterday approved the domestic sale of Zepid (avanafil), a new type of anti-impotency drug.
Created by JW Pharmaceutical, Zepid is Korea’s third homegrown erectile dysfunction medicine - Dong-A Pharmaceutical`s Zydena and SK Chemicals’ Mvix.
Avanafil is a next-generation, highly selective oral phosphodiesterase type 5 (PDE5) inhibitor therapy...
Created by JW Pharmaceutical, Zepid is Korea’s third homegrown erectile dysfunction medicine - Dong-A Pharmaceutical`s Zydena and SK Chemicals’ Mvix.
Avanafil is a next-generation, highly selective oral phosphodiesterase type 5 (PDE5) inhibitor therapy...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.